Apolipoprotein B and Low-Density Lipoprotein Cholesterol are Associated with Left Atrial Enlargement in Patients with Nonvalvular Atrial Fibrillation

被引:0
|
作者
Gong, Bojun [1 ]
Hu, Dajun [2 ]
Li, Zicheng [3 ,4 ]
Zhong, Qiaoqing
机构
[1] Guangzhou Xinju Kee & Trade Dev Co Ltd, Guangzhou, Peoples R China
[2] First Peoples Hosp Chenzhou, Dept Cardiol, Chenzhou, Peoples R China
[3] Jinan Univ, Dept Cardiol, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha 410300, Hunan, Peoples R China
关键词
atrial fibrillation; heart atria; humans; arrhythmia; ALPHA-HYDROXYBUTYRATE DEHYDROGENASE; CHA(2)DS(2)-VASC SCORES; THROMBOEMBOLIC RISK; STROKE; CHADS(2); STRATIFICATION; PREVALENCE; PREDICTION; PARAMETERS; MANAGEMENT;
D O I
10.6890/IJGE.202404_18(2).0010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Patients who had left atrial enlargement (LAE) with atrial fibrillation (AF) had an increased risk of LA dysfunction. However, there were few reports about the relationship between apolipoprotein B (apo B) and LAE or the association between low -density lipoprotein cholesterol (LDL-C) and LAE. We aimed to evaluated the above relationships in patients with non -valvular atrial fibrillation (NVAF). Methods: A total of 170 subjects were consecutively enrolled from December 2012 to July 2015.87 subjects were retrospectively enrolled as control group. 83 patients were retrospectively included in NVAF group. Heart color Doppler ultrasound examination of all the study subjects were diagnosed by medical specialists. Routine biochemical indicators of hematology were tested in clinical laboratory. Results: There were significant differences between the control and the NVAF group in terms of a - Hydroxybutyrate dehydrogenase ( a -HBDH), triglyceride (TG), total cholesterol (TC) and LDL-C. In total NVAF patients, both the CHADS 2 (r = 0.578, P = 0.000) and CHA 2 DS 2 -VASc (r = 0.632, P = 0.000) scores were positively correlated with age. The CHADS 2 score was negatively correlated with apo B (r = -0.217, P = 0.049), and the CHA 2 DS 2 -VASc score was negatively correlated with TG (r = -0.256, P = 0.019) and calcium ion (CA) (r = -0.285, P = 0.009). In Pearson correlation analysis, LA diameter was negatively correlated with LDL-C (r = -0.425, P = 0.001), apo B (r = -0.407, P = 0.001) and TC (r = -0.378, P = 0.002) in patients with total NVAF accompanied by LAE. Multiple stepwise regression analysis revealed that LDL-C was an important factor influencing LA size in patients with NVAF. Conclusion: In conclusion, apo B and LDL-C was associated with LAE in patients with NVAF, and LDL-C was an important factor influencing LA size in patients with NVAF. Copyright (c) 2024, Taiwan Society of Geriatric Emergency & Critical Care Medicine.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 50 条
  • [31] Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter
    Yang, Yankun
    Du, Xin
    Dong, Jianzeng
    Ma, Changsheng
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 358 (04) : 273 - 278
  • [32] Advanced age, low left atrial appendage velocity, and Factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation
    Zateyshchikov, Dmitry A.
    Brovkin, Alexey N.
    Chistiakov, Dimitry A.
    Nosikov, Valery V.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 30 (02) : 192 - 199
  • [33] Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation
    Dakay, Katarina
    Chang, Andrew D.
    Hemendinger, Morgan
    Cutting, Shawna
    McTaggart, Ryan A.
    Jayaraman, Mahesh V.
    Chu, Antony
    Panda, Nikhil
    Song, Christopher
    Merkler, Alexander
    Gialdini, Gino
    Kummer, Benjamin
    Lerario, Michael P.
    Kamel, Hooman
    Elkind, Mitchell S. V.
    Furie, Karen L.
    Yaghi, Shadi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (01) : 192 - 197
  • [34] Construction of a Clinical Predictive Model of Left Atrial and Left Atrial Appendage Thrombi in Patients with Nonvalvular Atrial Fibrillation
    Yin, Lei
    He, Changjian
    Zheng, Huixin
    Ma, Jianshuai
    Liu, Jinting
    Zhang, Xiaohong
    Xie, Ruiqin
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2022, 2022
  • [35] Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients
    Ke, Hong-hong
    He, Yan
    Lv, Xiang-wei
    Zhang, En-Hao
    Wei, Zhe
    Li, Jin-yi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) : 270 - 276
  • [36] Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis
    Su, Xin
    Cai, Xueli
    Pan, Yuesong
    Sun, Jingping
    Jing, Jing
    Wang, Mengxing
    Meng, Xia
    Wang, Yongjun
    Wei, Tiemin
    He, Yan
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (18) : 2349 - 2358
  • [37] Oxidized Low-Density Lipoprotein Predicts the Development of Renal Dysfunction in Atrial Fibrillation
    Polovina, Marija
    Petrovic, Ivana
    Brkovic, Voin
    Asanin, Milika
    Marinkovic, Jelena
    Ostojic, Miodrag
    CARDIORENAL MEDICINE, 2017, 7 (01) : 31 - 41
  • [38] Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation
    Choi, Seo-Won
    Kim, Bo-Bae
    Choi, Dong-Hyun
    Park, Geon
    Shin, Byung Chul
    Song, Heesang
    Kim, DongHun
    Kim, Dong-Min
    CLINICAL CARDIOLOGY, 2017, 40 (11) : 1013 - 1019
  • [39] Relationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutter
    Narumiya, T
    Sakamaki, T
    Sato, Y
    Kanmatsuse, K
    CIRCULATION JOURNAL, 2003, 67 (01) : 68 - 72
  • [40] Left atrial appendage orifice area and morphology is closely associated with flow velocity in patients with nonvalvular atrial fibrillation
    Lei Chen
    Changjiang Xu
    Wensu Chen
    Chaoqun Zhang
    BMC Cardiovascular Disorders, 21